ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics

The Preclinical Working Group of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership spearheaded by the National Institutes of Health, has been charged with identifying, prioritizing, and communicating SARS-CoV-2 preclinical resources. Reviewing SARS-Co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Host Microbe
Autores principales: Hewitt, Judith A., Lutz, Cathleen, Florence, William C., Pitt, M. Louise M., Rao, Srinivas, Rappaport, Jay, Haigwood, Nancy L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Cell Press 2020
Materias:
Perspective
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528903/
https://ncbi.nlm.nih.gov/pubmed/33152279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chom.2020.09.016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares